Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: OTC labeling

This article was originally published in The Tan Sheet

Executive Summary

OTC labeling: Emory University School of Medicine, Texas Panhandle Poison Center and Washington Poison Center submit separate objections to FDA's proposal to delete from OTC product labels the recommendation to call a poison control center in the event of an overdose. The commentors maintain that advising consumers to "get medical help right away," the proposed wording, may encourage people to go to hospital emergency rooms without first checking to see whether the overdose is medically significant. FDA published the proposed OTC drug labeling reg in the Feb. 27 Federal Register ("The Tan Sheet" March 3, pp. 1-9)...

OTC labeling: Emory University School of Medicine, Texas Panhandle Poison Center and Washington Poison Center submit separate objections to FDA's proposal to delete from OTC product labels the recommendation to call a poison control center in the event of an overdose. The commentors maintain that advising consumers to "get medical help right away," the proposed wording, may encourage people to go to hospital emergency rooms without first checking to see whether the overdose is medically significant. FDA published the proposed OTC drug labeling reg in the Feb. 27 Federal Register ("The Tan Sheet" March 3, pp. 1-9)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel